KTRA : Insider Transactions for Kintara Therapeutics, Inc

Company Profile Kintara Therapeutics is a clinical stage, biopharmaceutical company focused on the development and commercialization of new cancer therapies. Co.'s two primary candidates are: VAL-083, a validated, DNA-targeting agent, for the treatment of drug-resistant solid tumors such as glioblastoma multiforme and potentially other solid tumors, including ovarian cancer, non-small cell lung cancer, and diffuse intrinsic pontine glioma; and REM-001, a late-stage photodynamic therapy for the treatment of cutaneous metastatic breast cancer, basal cell carcinoma nevus syndrome, and access graft failure in hemodialysis patients.

D/I:

D is for direct shares.
I is for indirect shares.

D/I refers to the Direct or Indirect shares traded vs. held.

Forms:

A Form 4 is a form filed by an insider to indicate a change in ownership.

A Form 3 is a form filed by an insider to indicate an initial ownership of a security.

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.

Actions:

B	Buy
S	Sell
OE	Option Exercised
A	Acquired
D	Disposed
AB	Automatic Buy
AS	Automatic Sell
IO	Initial Ownership

Download:

Download only Transactions Forms. (Default)

Download only Summary Infomation.

Download both Transactions and Summary Data

Summary (Direct Transactions Only)	3 Months	6 Months	12 Months	24 Months
Total Shares Bought	0	0	0	0
Total Buy Value	$0	$0	$0	$0
Total People Bought	0	0	0	0
Total Buy Transactions	0	0	0	0
Total Shares Sold	0	0	0	0
Total Sell Value	$0	$0	$0	$0
Total People Sold	0	0	0	0
Total Sell Transactions	0	0	0	0
End Date	2024-02-18	2023-11-17	2023-05-19	2022-05-19

Adjust Filter Settings

Records found: 165

Page 4 of 7

Filer's Name

Relation Title

Off-Dir-10%

Tran. Date

Form

Action

Price

Mkt Value

D/I

Shares

Holdings

Rank

3m +/-

Form

Cranston Lynda Sarah

Director

– • –

2018-03-30

$3.20

$227

I/I

2,628

Praill Scott

Chief Financial Officer

• – –

2018-03-30

$3.20

$675

D/D

211

72,788

Bell John K

Director

– • –

2017-12-31

$3.20

$902

I/I

282

95,301

Mohr Erich

Director

– • –

2017-12-31

$3.20

$1,690

D/D

528

7,694

Cranston Lynda Sarah

Director

– • –

2017-12-31

$3.20

$227

I/I

2,557

Brown Dennis M

Chief Scientific Officer

• • –

2017-12-31

$3.20

$541

D/D

169

218,415

Bacha Jeffrey

Director

– • –

2017-12-31

$3.20

$563

D/D

176

63,873

Praill Scott

Chief Financial Officer

• – –

2017-12-31

$0.00

D/D

25,000

72,577

Praill Scott

Chief Financial Officer

• – –

2017-12-31

$3.20

$675

D/D

211

47,577

Toth Robert Joseph Jr

Director

– • –

2017-12-31

$3.20

$237

D/D

11,369

Brown Dennis M

Chief Scientific Officer

• • –

2017-12-13

$0.00

D/D

129,600

218,246

Bell John K

Director

– • –

2017-11-16

$0.81

$14,684

I/I

18,129

95,019

2.1

Bell John K

Director

– • –

2017-11-15

$0.81

$1,516

I/I

1,871

76,890

2.02

Zarrabian Saiid

Interim CEO

• • –

2017-11-14

$0.84

$4,956

I/I

5,900

2.58

Zarrabian Saiid

Interim CEO

• • –

2017-11-14

$0.82

$45,100

D/D

55,000

2.81

Bacha Jeffrey

CEO

• • –

2017-10-06

$0.87

$8,725

D/D

10,000

63,697

2.81

Praill Scott

Chief Financial Officer

• – –

2017-10-05

$0.85

$14,910

D/D

17,500

47,366

2.74

Bell John K

Director

– • –

2017-09-29

$3.20

$902

I/I

282

75,019

Bacha Jeffrey

CEO

• • –

2017-09-29

$3.20

$563

D/D

176

53,697

Mohr Erich

Director

– • –

2017-09-29

$3.20

$1,690

D/D

528

7,166

Cranston Lynda Sarah

Director

– • –

2017-09-29

$3.20

$227

I/I

2,486

Praill Scott

Chief Financial Officer

• – –

2017-09-29

$3.20

$675

D/D

211

29,866

Brown Dennis M

Chief Scientific Officer

• • –

2017-09-29

$3.20

$541

I/I

169

885,346

Toth Robert Joseph Jr

Director

– • –

2017-09-29

$3.20

$237

D/D

11,295

Bell John K

Director

– • –

2017-08-01

$0.00

D/D

25,000

74,737

165 Records found	1 2 3 4 5 6 7	Page 4 of 7

Transaction Code Key:				Ownership Code Key
B	- Buy	AB	- Automatic Buy	D	- Direct Ownership
S	- Sell	AS	- Automatic Sell	I	- Indirect Ownership
OE	- Options Exercised	A	- Acquired
IO	- Initital Ownership	D	- Disposed

Summary:

Chart:

3m +/-: